Association of metals with the risk and clinical characteristics of Parkinson's disease. Parkinsonism Relat Disord. 2018 May 28. S1353-8020(18)30254-2.
Hand Tremor Questionnaire: A Useful Screening Tool for Differentiating Patients with Hand Tremor between Parkinson's Disease and Essential Tremor. J Clin Neurol. 2018 Jul;14(3):381-386.
Validation of the Korean Version of the Scales for Outcomes in Parkinson's Disease-Sleep. J Korean Med Sci. 2018 Jan 8;33(2):e14.
Hypersexuality induced by rasagililne monotherapy in a patient with Parkinson’s disease. J Korean Neurol Assoc 2017;35(4):235-236
Quantitative Gait Analysis in Patients with Huntington’s Disease. J Mov Disord. 2017;10(3):140-144.
Comparison of Pallidal and Subthalamic Deep Brain Stimulation in Parkinson's Disease: Therapeutic and Adverse Effects. J Mov Disord. 2017;10(2):80-86.
Lack of association of mortalin (HSPA9) and other mitochondria-related genes with risk of Parkinson's and Alzheimer's diseases. Neurobiol Aging. 2017 Jan;49:215.e9-215.e10.
Validation of the Korean Version of the Scale for Outcomes in Parkinson's Disease-Autonomic. J Mov Disord. 2017 Jan;10(1):29-34.
Mortality of advanced Parkinson's disease patients treated with deep brain stimulation surgery. J Neurol Sci. 2016 Oct 15;369:230-5.
Alpha-synuclein in gastric and colonic mucosa in Parkinson’s disease: limited role as a biomarker. Mov Disord. 2016 Feb;31(2):241-9.
Association of Type 2 Diabetes GWAS Loci and the Risk of Parkinson’s and Alzheimer’s Diseases. Parkinsonism Relat Disord. 2015 Dec;21(12):1435-40.
Neural substrates of motor and non-motor symptoms in Parkinson's disease: a resting FMRI study. PLoS One. 2015 Apr 24;10(4)
Chorea due to diabetic hyperglycemia and uremia: distinct clinical and imaging features. Mov Disord. 2015 Mar;30(3):419-22
Clinical features of drug-induced parkinsonism based on [18F] FP-CIT positron emission tomography. Neurol Sci. 2015 Feb;36(2):269-74.